These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8248084)

  • 1. [Non-enzymatic glycosylation of proteins. Complications of diabetes mellitus, aging and kidney failure].
    Monnier V
    Presse Med; 1993 Oct; 22(30):1413-8. PubMed ID: 8248084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes.
    Sady C; Khosrof S; Nagaraj R
    Biochem Biophys Res Commun; 1995 Sep; 214(3):793-7. PubMed ID: 7575546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
    Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Maillard reaction in the human body. The main discoveries and factors that affect glycation.
    Tessier FJ
    Pathol Biol (Paris); 2010 Jun; 58(3):214-9. PubMed ID: 19896783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
    Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
    Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia.
    Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA
    Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteins modified in the nonenzymatically glycosylation reaction (AGE-proteins)--new markers for diabetes?].
    Zdrojewicz Z; Januszewski A; Kwiatkowska D
    Postepy Hig Med Dosw; 1994; 48(6):689-700. PubMed ID: 7675730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and repair of protein damage by the Maillard reaction in vivo.
    Monnier VM; Sell DR
    Rejuvenation Res; 2006; 9(2):264-73. PubMed ID: 16706654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pentosidine: a new biomarker in diabetes mellitus complications].
    Morales S; García-Salcedo JA; Muñoz-Torres M
    Med Clin (Barc); 2011 Mar; 136(7):298-302. PubMed ID: 20226481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
    Beisswenger PJ; Moore LL; Brinck-Johnsen T; Curphey TJ
    J Clin Invest; 1993 Jul; 92(1):212-7. PubMed ID: 8325987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of proteins by methylglyoxal.
    Degenhardt TP; Thorpe SR; Baynes JW
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Maillard products in the chronic complications of diabetes mellitus. Bioclinical applications].
    Trivin F
    Ann Pharm Fr; 1998; 56(5):193-6. PubMed ID: 9805817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Maillard reaction and food allergies: is there a link?
    Toda M; Heilmann M; Ilchmann A; Vieths S
    Clin Chem Lab Med; 2014 Jan; 52(1):61-7. PubMed ID: 23492561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane.
    Sell DR; Carlson EC; Monnier VM
    Diabetologia; 1993 Oct; 36(10):936-41. PubMed ID: 8243873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native protein glycoxidation and aging.
    Meli M; Frey J; Perier C
    J Nutr Health Aging; 2003; 7(4):263-6. PubMed ID: 12917752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
    Padival S; Nagaraj RH
    Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.